{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:22:56Z","timestamp":1791285776383,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondecyt-CHILE","award":["1130675"],"award-info":[{"award-number":["1130675"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Genetic factors can determine the high variability observed in response to  lipid-lowering therapy with statins. Nonetheless, the frequency of single nucleotide polymorphisms (SNPs) and their impact can vary due to ethnicity. Because the Chilean population carries a strong Amerindian background, the objective of this study was to evaluate the influence of apolipoprotein E (APOE) variants (rs429358, rs7412) and the 1959C&gt;T SNP (rs5925) in the low-density lipoprotein receptor (LDLR) in response to atorvastatin treatment in hypercholesterolemic individuals. A hundred and thirty nine subjects undergoing statin therapy were included. Identification of Amerindian mtDNA haplogroups was determined by polymerase chain reaction (PCR) and PCR followed by restriction fragment length polymorphism (RFLP), respectively. SNPs were determined by PCR-RFLP. Out of the 139 individuals studied, 84.4% had an Amerindian background, according to mtDNA analysis. In relation to APOE variants, carriers of the E3\/4 genotype presented lower cholesterol reduction compared to genotype E3\/3 (LDL-C: \u221218% vs. \u221229%, p \u02c2 0.001). On the other hand, the LDLR rs5925 SNP was not related to atorvastatin response (p = 0.5760). Our results suggest that APOE SNPs are potential predictors to atorvastatin therapy in Amerindian Chilean subjects.<\/jats:p>","DOI":"10.3390\/ijms16047890","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T10:44:31Z","timestamp":1428576271000},"page":"7890-7899","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects"],"prefix":"10.3390","volume":"16","author":[{"given":"Jenny","family":"Lagos","sequence":"first","affiliation":[{"name":"Center of Molecular Biology and Pharmacogenetics, Department of Basic Sciences,  Scientific and Technological Bioresource Nucleus, Universidad de La Frontera (BIOREN-UFRO),  Av. Francisco Salazar 01145, 4811230 Temuco, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Zambrano","sequence":"additional","affiliation":[{"name":"Center of Molecular Biology and Pharmacogenetics, Department of Basic Sciences,  Scientific and Technological Bioresource Nucleus, Universidad de La Frontera (BIOREN-UFRO),  Av. Francisco Salazar 01145, 4811230 Temuco, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexy","family":"Rosales","sequence":"additional","affiliation":[{"name":"Center of Molecular Biology and Pharmacogenetics, Department of Basic Sciences,  Scientific and Technological Bioresource Nucleus, Universidad de La Frontera (BIOREN-UFRO),  Av. Francisco Salazar 01145, 4811230 Temuco, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5112-6944","authenticated-orcid":false,"given":"Luis","family":"Salazar","sequence":"additional","affiliation":[{"name":"Center of Molecular Biology and Pharmacogenetics, Department of Basic Sciences,  Scientific and Technological Bioresource Nucleus, Universidad de La Frontera (BIOREN-UFRO),  Av. Francisco Salazar 01145, 4811230 Temuco, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138161211795428858","article-title":"Cardiovascular disease and dyslipidemia: Beyond LDL","volume":"17","author":"Poss","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2004.09.004","article-title":"Pharmacogenetics of HMG-CoA reductase inhibitors: Exploring the potential for genotype-based individualization of coronary heart disease management","volume":"177","author":"Kajinami","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vph.2005.07.012","article-title":"Pharmacogenomics of cholesterol-lowering therapy","volume":"44","author":"Schmitz","year":"2006","journal-title":"Vascul. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"65K","DOI":"10.1016\/j.amjcard.2005.08.011","article-title":"Pharmacogenomics of statin responsiveness","volume":"96","author":"Kajinami","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1098-2825(2000)14:3<125::AID-JCLA7>3.0.CO;2-S","article-title":"Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia","volume":"14","author":"Salazar","year":"2000","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.metabol.2004.12.020","article-title":"Baseline levels of low-density lipoprotein cholesterol and lipoprotein(a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment","volume":"54","author":"Lahoz","year":"2005","journal-title":"Metabolism"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjcard.2003.08.078","article-title":"CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia","volume":"93","author":"Kajinami","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2008.07.032","article-title":"CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia","volume":"398","author":"Willrich","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.tpj.6500334","article-title":"Determinants of variable response to simvastatin treatment: The role of common variants of SCAP, SREBF-1A and SREBF-2 genes","volume":"5","author":"Fiegenbaum","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"ref_11","first-page":"S400","article-title":"Ethnic, gender, and age-related differences in the treatment of dyslipidemia","volume":"12","author":"Ferdinand","year":"2006","journal-title":"Am. J. Manag. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjcard.2005.09.134","article-title":"Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study","volume":"97","author":"Simon","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.107.708388","article-title":"Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment","volume":"117","author":"Krauss","year":"2008","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X","article-title":"Mitochondrial DNA polymorphisms in Chilean aboriginal populations: Implications for the peopling of the southern cone of the continent","volume":"113","author":"Moraga","year":"2000","journal-title":"Am. J. Phys. Anthropol."},{"key":"ref_15","first-page":"125","article-title":"Genetic composition of the Chilean population. Analysis of mitochondrial DNA polymorphism","volume":"130","author":"Rocco","year":"2002","journal-title":"Rev. Med. Chile"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1469-1809.1996.tb01194.x","article-title":"Multiple founder haplotypes of mitochondrial DNA in Amerindians revealed by RFLP and sequencing","volume":"60","author":"Santos","year":"1996","journal-title":"Ann. Hum. Genet."},{"key":"ref_17","first-page":"27","article-title":"Founder mitochondrial haplotypes in Amerindian populations","volume":"55","author":"Bailliet","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"ref_18","first-page":"542","article-title":"Association between AvaII exon 13 polymorphism at the LDL receptor gene different and serum lipid levels in normotensives and essential hypertensives in Shanghai","volume":"24","author":"Liu","year":"2003","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Long, X.J., Yin, R.X., Li, K.L., Liu, W.Y., Zhang, L., Cao, X.L., Miao, L., Wu, D.F., Htet Aung, L.H., and Hu, X.J. (2011). Low density lipoprotein receptor gene Ava II polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Lipids Health Dis., 10.","DOI":"10.1186\/1476-511X-10-34"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1067\/mhj.2002.130300","article-title":"Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"144","author":"Istvan","year":"2002","journal-title":"Am. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: Insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.ATV.14.5.663","article-title":"Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population","volume":"14","author":"Ahn","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"ref_23","first-page":"30","article-title":"The relationship of low density lipoprotein receptor gene polymorphism and hyperlipidemia","volume":"22","author":"Liu","year":"2001","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: Far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physiolgenomics.2000.4.2.101","article-title":"APOE gene and gene-environment effects on plasma lipoprotein-lipid levels","volume":"4","author":"Hagberg","year":"2000","journal-title":"Physiol. Genomics"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Baptista, R., Rebelo, M., Decq-Mota, J., Dias, P., Monteiro, P., Providencia, L.A., and Silva, J.M. (2011). Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy. Lipids Health Dis., 10.","DOI":"10.1186\/1476-511X-10-48"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7B","DOI":"10.1016\/S0002-9149(98)00031-9","article-title":"Hypertriglyceridemia as a cardiovascular risk factor","volume":"81","author":"Austin","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"ref_28","first-page":"M8","article-title":"The emergence of triglycerides as a significant independent risk factor in coronary artery disease","volume":"19","author":"Assmann","year":"1998","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40291-014-0094-3","article-title":"Influence of SREBP-2 and SCAP gene polymorphisms on lipid-lowering response to atorvastatin in a cohort of Chilean subjects with Amerindian background","volume":"18","author":"Lagos","year":"2014","journal-title":"Mol. Diagn. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s004390100602","article-title":"Association of the mitochondrial DNA 5178 A\/C polymorphism with serum lipid levels in the Japanese population","volume":"109","author":"Kokaze","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"National Heart, Lung, and Blood Institute. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/clinchem\/44.8.1748","article-title":"Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing","volume":"44","author":"Salazar","year":"1998","journal-title":"Clin. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/4\/7890\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:44:28Z","timestamp":1760215468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/4\/7890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4]]}},"alternative-id":["ijms16047890"],"URL":"https:\/\/doi.org\/10.3390\/ijms16047890","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}